PDE4B and cardiovascular disorder: This included theophylline and its derivatives (dyphylline and enprofylline), selective PDE4B inhibitors (cilomilast and roflumilast), and other drugs indicated for cardiovascular disease (amrinone and trapidil) or patients with COPD (roflumilast and cilomilast).